Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Interim Management Statement

16 Nov 2012 07:00

RNS Number : 2676R
Gleeson(M J)Group PLC
16 November 2012
 



Friday 16 November 2012

 

 

M J GLEESON GROUP PLC

 

INTERIM MANAGEMENT STATEMENT

 

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces its Interim Management Statement, covering the period from 1 July 2012 to 15 November 2012, in accordance with the UK Listing Authority's Disclosure and Transparency Rules.

 

Gleeson operates as the following divisions:

 

·; a housebuilder, mainly in the North of England, with a particular focus on low cost homes for local people;

 

·; a strategic land development business, mainly in the South of England, that enhances the value of land, principally held under option, through the planning process;

 

Gleeson Homes

 

Total sales, comprising reserved, contracted and completed homes, are up by 42% from a year ago.

 

Since the beginning of the period we have opened six new sites, two in each region. A total of 26 sites are currently open.

 

Prices for units being sold are in line with management's expectations at an average of £119,000. This is a decrease of £9,000 from the prior year due to a change in geographic mix. The proportion of units being sold on recently acquired higher margin sites has improved significantly since the prior year, with only 25% of total sales noted above from old, low margin sites, compared to 64% in the comparable period.

 

The housing market in the North of England remains challenging and weekly sales rates have on occasion fallen below expectations. Nonetheless, the division's very successful control of costs, coupled with the substantial increase in the number of new higher margin selling outlets, has meant that the overall level of sales achieved during the period will deliver a substantially improved level of profitability.

 

As previously reported, mortgage availability continues to remain restricted. However, we have seen a significant level of interest in the Government's FirstBuy scheme, which provides support to first time buyers by way of a 20% equity loan. In addition, Gleeson Homes is one of the first developers to have secured a low interest loan for site specific development from the Government's Get Britain Building Fund.

 

Five sites have been purchased during the period, which have added 331 plots to the Group's land bank. The Group is currently in discussions regarding the acquisition of a further 13 sites, which, if purchased, will add 1,082 plots to the land bank, taking the total number of plots to in excess of 3,700.

 

Gleeson Strategic Land

 

During the period, Gleeson Strategic Land has sold two significant sites and continues to replenish the portfolio, entering three new agreements since 1 July 2012, comprising 170 acres and, potentially, 1,000 plots.

 

The volume housebuilders continue to display a strong appetite for green field residential land in the South of England and Gleeson Strategic Land is experiencing a high level of interest in the sites which it hopes to bring to the market in the remainder of the year.

 

Outlook

 

The Board is encouraged by the achievements of both Gleeson Homes and Gleeson Strategic Land in challenging circumstances and remains confident that they are laying the foundations of a strong and sustainable improvement in the Group's performance.

 

 

 

 

 

 

Enquiries:

 

M J Gleeson Group plc 01252 360 300

 

Jolyon Harrison Chief Executive Officer

Alan Martin Chief Financial Officer

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMMMMVKDGZZM
Date   Source Headline
11th Jan 20224:38 pmRNSDirector/PDMR Shareholding
11th Jan 20227:00 amRNSNotice of Results & Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
8th Dec 20212:47 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSTotal Voting Rights
26th Nov 20214:50 pmRNSDirector/PDMR Shareholding - Amendment
26th Nov 20214:49 pmRNSDirector/PDMR Shareholding
15th Nov 202112:52 pmRNSResult of AGM
15th Nov 20217:00 amRNSAGM Statement
8th Nov 20211:50 pmRNSDirector/PDMR Shareholding
4th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20218:29 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSTotal Voting Rights
26th Oct 20219:38 amRNSDirector/PDMR Shareholding
15th Oct 20214:41 pmRNSSecond Price Monitoring Extn
15th Oct 20214:36 pmRNSPrice Monitoring Extension
13th Oct 202112:48 pmRNSNotice of AGM
8th Oct 20211:22 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSPerformance Share Plan award to PDMRs
30th Sep 20217:00 amRNSTotal Voting Rights
28th Sep 20214:09 pmRNSPerformance Share Plan award to Directors
28th Sep 20214:06 pmRNSDirector/PDMR Shareholding
15th Sep 202110:33 amRNSDirector/PDMR Shareholding - Amendment
14th Sep 20217:00 amRNSAudited results for the year ended 30 June 2021
8th Sep 202111:14 amRNSDirector/PDMR Shareholding
31st Aug 20217:00 amRNSTotal Voting Rights
9th Aug 20214:37 pmRNSPrice Monitoring Extension
9th Aug 20211:11 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
21st Jul 20217:00 amRNSLong Term Incentive Plan award to Director
9th Jul 20219:41 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSNotice of Results & Trading Update
7th Jul 20214:47 pmRNSDirector/PDMR Shareholding
30th Jun 20217:00 amRNSTotal Voting Rights
8th Jun 20214:44 pmRNSDirector/PDMR Shareholding
28th May 20217:00 amRNSTotal Voting Rights
24th May 20217:00 amRNSTrading Update
7th May 20214:33 pmRNSDirector/PDMR Shareholding
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20212:02 pmRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSTotal Voting Rights
26th Mar 20214:08 pmRNSRe Committee appointments
22nd Mar 20218:34 amRNSPerformance Share Plan award to Directors/PDMRs
8th Mar 20211:44 pmRNSDirector/PDMR Shareholding
1st Mar 20217:00 amRNSRe Directorate
26th Feb 20217:00 amRNSTotal Voting Rights
11th Feb 20217:00 amRNSHalf-year Report
8th Feb 20215:07 pmRNSDirector/PDMR Shareholding
29th Jan 20217:00 amRNSTotal Voting Rights
11th Jan 20217:00 amRNSNotice of Results & Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.